Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Dec;62(6):976–981. doi: 10.1038/bjc.1990.420

The prognostic value of DNA-ploidy in colorectal carcinoma: a prospective study.

M Kouri 1, S Pyrhönen 1, J P Mecklin 1, H Järvinen 1, A Laasonen 1, K Franssila 1, S Nordling 1
PMCID: PMC1971551  PMID: 2257229

Abstract

One hundred and fifty-seven patients with usual colorectal cancer were analysed prospectively for DNA-ploidy, DNA-index and S-phase fraction (SPF) using flow cytometry. An abnormal DNA-stemline was observed in 68% of tumours. The patients have been followed for a median of 36 months. In univariate analysis, tumour stage was the most significant prognostic factor. After excluding patients with stage D disease, DNA-aneuploidy was significantly associated with a shorter survival and a shorter disease free survival. SPF, however, did not correlate with prognosis. In multiple samples from the same tumour there was on average a 29% difference between the highest and the lowest SPF indicating considerable heterogeneity in proliferative activity within the tumours. In diploid tumours the variation was even higher. Patients with proximal tumours as well as female patients had DNA-diploid tumours more often than the others. This may indicate that there are different, so far unknown, aetiological factors leading to different types of ploidy pattern.

Full text

PDF
978

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armitage N. C., Robins R. A., Evans D. F., Turner D. R., Baldwin R. W., Hardcastle J. D. The influence of tumour cell DNA abnormalities on survival in colorectal cancer. Br J Surg. 1985 Oct;72(10):828–830. doi: 10.1002/bjs.1800721018. [DOI] [PubMed] [Google Scholar]
  2. Baisch H., Göhde W., Linden W. A. Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle. Radiat Environ Biophys. 1975 Jun 13;12(1):31–39. doi: 10.1007/BF02339807. [DOI] [PubMed] [Google Scholar]
  3. Bauer K. D., Lincoln S. T., Vera-Roman J. M., Wallemark C. B., Chmiel J. S., Madurski M. L., Murad T., Scarpelli D. G. Prognostic implications of proliferative activity and DNA aneuploidy in colonic adenocarcinomas. Lab Invest. 1987 Sep;57(3):329–335. [PubMed] [Google Scholar]
  4. DUKES C. E., BUSSEY H. J. The spread of rectal cancer and its effect on prognosis. Br J Cancer. 1958 Sep;12(3):309–320. doi: 10.1038/bjc.1958.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davis N. C., Newland R. C. Terminology and classification of colorectal adenocarcinoma: the Australian clinico-pathological staging system. Aust N Z J Surg. 1983 Jun;53(3):211–221. doi: 10.1111/j.1445-2197.1983.tb02430.x. [DOI] [PubMed] [Google Scholar]
  6. Goh H. S., Jass J. R., Atkin W. S., Cuzick J., Northover J. M. Value of flow cytometric determination of ploidy as a guide to prognosis in operable rectal cancer: a multivariate analysis. Int J Colorectal Dis. 1987 Feb;2(1):17–21. doi: 10.1007/BF01648992. [DOI] [PubMed] [Google Scholar]
  7. Jones D. J., Moore M., Schofield P. F. Refining the prognostic significance of DNA ploidy status in colorectal cancer: a prospective flow cytometric study. Int J Cancer. 1988 Feb 15;41(2):206–210. doi: 10.1002/ijc.2910410208. [DOI] [PubMed] [Google Scholar]
  8. Kallioniemi O. P., Blanco G., Alavaikko M., Hietanen T., Mattila J., Lauslahti K., Lehtinen M., Koivula T. Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer. Cancer. 1988 Nov 15;62(10):2183–2190. doi: 10.1002/1097-0142(19881115)62:10<2183::aid-cncr2820621019>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  9. Kallioniemi O. P., Punnonen R., Mattila J., Lehtinen M., Koivula T. Prognostic significance of DNA index, multiploidy, and S-phase fraction in ovarian cancer. Cancer. 1988 Jan 15;61(2):334–339. doi: 10.1002/1097-0142(19880115)61:2<334::aid-cncr2820610224>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  10. Knudson A. G., Jr Hereditary cancers disclose a class of cancer genes. Cancer. 1989 May 15;63(10):1888–1891. doi: 10.1002/1097-0142(19890515)63:10<1888::aid-cncr2820631004>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  11. Kokal W., Sheibani K., Terz J., Harada J. R. Tumor DNA content in the prognosis of colorectal carcinoma. JAMA. 1986 Jun 13;255(22):3123–3127. [PubMed] [Google Scholar]
  12. Kouri M., Laasonen A., Mecklin J. P., Järvinen H., Franssila K., Pyrhönen S. Diploid predominance in hereditary nonpolyposis colorectal carcinoma evaluated by flow cytometry. Cancer. 1990 Apr 15;65(8):1825–1829. doi: 10.1002/1097-0142(19900415)65:8<1825::aid-cncr2820650827>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  13. Mecklin J. P. Frequency of hereditary colorectal carcinoma. Gastroenterology. 1987 Nov;93(5):1021–1025. doi: 10.1016/0016-5085(87)90565-8. [DOI] [PubMed] [Google Scholar]
  14. Melamed M. R., Enker W. E., Banner P., Janov A. J., Kessler G., Darzynkiewicz Z. Flow cytometry of colorectal carcinoma with three-year follow-up. Dis Colon Rectum. 1986 Mar;29(3):184–186. doi: 10.1007/BF02555020. [DOI] [PubMed] [Google Scholar]
  15. Quirke P., Dixon M. F., Clayden A. D., Durdey P., Dyson J. E., Williams N. S., Bird C. C. Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol. 1987 Apr;151(4):285–291. doi: 10.1002/path.1711510408. [DOI] [PubMed] [Google Scholar]
  16. Rognum T. O., Thorud E., Lund E. Survival of large bowel carcinoma patients with different DNA ploidy. Br J Cancer. 1987 Nov;56(5):633–636. doi: 10.1038/bjc.1987.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Schutte B., Reynders M. M., Wiggers T., Arends J. W., Volovics L., Bosman F. T., Blijham G. H. Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma. Cancer Res. 1987 Oct 15;47(20):5494–5496. [PubMed] [Google Scholar]
  18. Scott N. A., Rainwater L. M., Wieand H. S., Weiland L. H., Pemberton J. H., Beart R. W., Jr, Lieber M. M. The relative prognostic value of flow cytometric DNA analysis and conventional clinicopathologic criteria in patients with operable rectal carcinoma. Dis Colon Rectum. 1987 Jul;30(7):513–520. doi: 10.1007/BF02554780. [DOI] [PubMed] [Google Scholar]
  19. Scott N. A., Wieand H. S., Moertel C. G., Cha S. S., Beart R. W., Lieber M. M. Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern. Arch Surg. 1987 Dec;122(12):1375–1379. doi: 10.1001/archsurg.1987.01400240021002. [DOI] [PubMed] [Google Scholar]
  20. Seckinger D., Sugarbaker E., Frankfurt O. DNA content in human cancer. Application in pathology and clinical medicine. Arch Pathol Lab Med. 1989 Jun;113(6):619–626. [PubMed] [Google Scholar]
  21. Shapiro H. M. Flow cytometry of DNA content and other indicators of proliferative activity. Arch Pathol Lab Med. 1989 Jun;113(6):591–597. [PubMed] [Google Scholar]
  22. Vindeløv L. L., Christensen I. J., Nissen N. I. Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry. 1983 Mar;3(5):328–331. doi: 10.1002/cyto.990030504. [DOI] [PubMed] [Google Scholar]
  23. Wiggers T., Arends J. W., Schutte B., Volovics L., Bosman F. T. A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer. 1988 Jan 15;61(2):386–395. doi: 10.1002/1097-0142(19880115)61:2<386::aid-cncr2820610231>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  24. Wolley R. C., Schreiber K., Koss L. G., Karas M., Sherman A. DNA distribution in human colon carcinomas and its relationship to clinical behavior. J Natl Cancer Inst. 1982 Jul;69(1):15–22. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES